Gilbane Building Ranked #5 Pharmaceuticals Builder in the U.S. by Engineering News-Record (ENR) 

Gilbane Building has been recognized as the #5 pharmaceuticals builder in the United States by Engineering News-Record (ENR) in its 2025 Top 400 Sourcebook. This ranking reflects Gilbane’s continued leadership and excellence in delivering complex, high-performance facilities for the pharma and biotech industries.  

As the demand for advanced therapeutics and precision medicines grows, Gilbane remains at the forefront, partnering with clients to build state-of-the-art facilities that bring medication to patients. Our teams bring deep expertise in the planning and construction of cGMP facilities, compliance, process innovation and automation, and energy efficiency, ensuring every project meets the rigorous standards of the pharmaceutical and biotechnology industries. 

Gilbane’s recent experience spans biopharma R&D and medical research laboratories, drug substance and drug product manufacturing, high containment and cleanrooms, packaging, and cGMP storage and distribution/logistics facilities. Clients include leading Fortune 100 pharmaceutical and biotechnology companies, as well as mid-sized and emerging biotech firms driving innovation and advanced therapies. 

As Gilbane continues to be an industry leader, we remain focused on driving innovation and delivering exceptional value to our clients and patients.